Home » Topics » Regulatory » Patents

Patents
RSS

Potent and selective D4 receptor ligands disclosed by Sumitomo

July 2, 1998

Novel antitumor agents prepared at Kanebo

July 2, 1998

Daiichi's new antibacterial agents

July 2, 1998

Antiretroviral DAD isosteres and HIV protease inhibitors claimed by HHS

July 2, 1998

Na+/H+ exchange inhibitors from Kanebo useful for cardiac ischemia

July 1, 1998

Glutamate transport blockers discovered using novel system developed at Suntory

July 1, 1998

Kyowa Hakko prepares new compounds for pruritus, asthma

July 1, 1998

Asta Medica investigates compounds for immune and allergic disorders

July 1, 1998

New antitumor agent disclosed in patent literature by Taisho

July 1, 1998

Modulators of the activity of IL-13 investigated at Amrad

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...